These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18311511)

  • 1. Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery.
    Baker C; Petrich de Marquesini LG; Bishop AJ; Hedges AJ; Dayan CM; Wong FS
    J Clin Immunol; 2008 Jul; 28(4):350-60. PubMed ID: 18311511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells.
    Kronenberg D; Knight RR; Estorninho M; Ellis RJ; Kester MG; de Ru A; Eichmann M; Huang GC; Powrie J; Dayan CM; Skowera A; van Veelen PA; Peakman M
    Diabetes; 2012 Jul; 61(7):1752-9. PubMed ID: 22522618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
    Mallone R; Scotto M; Janicki CN; James EA; Fitzgerald-Miller L; Wagner R; Gottlieb P; Thorpe J; Jospe N; Durinovic-Bellò I; Boitard C; Lou O; Dayan CM; Wong FS;
    Diabetes Metab Res Rev; 2011 Nov; 27(8):720-6. PubMed ID: 22069251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity.
    Abreu JR; Martina S; Verrijn Stuart AA; Fillié YE; Franken KL; Drijfhout JW; Roep BO
    Clin Exp Immunol; 2012 Oct; 170(1):57-65. PubMed ID: 22943201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
    Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
    Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
    van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
    Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
    Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
    J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.
    Mallone R; Brezar V; Boitard C
    Clin Dev Immunol; 2011; 2011():513210. PubMed ID: 21785617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.
    Skowera A; Ellis RJ; Varela-Calviño R; Arif S; Huang GC; Van-Krinks C; Zaremba A; Rackham C; Allen JS; Tree TI; Zhao M; Dayan CM; Sewell AK; Unger WW; Drijfhout JW; Ossendorp F; Roep BO; Peakman M
    J Clin Invest; 2008 Oct; 118(10):3390-402. PubMed ID: 18802479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
    Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
    J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes.
    Rathmann S; Rajasalu T; Rosinger S; Schlosser M; Eiermann T; Boehm BO; Durinovic-Belló I
    Ann N Y Acad Sci; 2004 Dec; 1037():22-5. PubMed ID: 15699489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of preproinsulin peptides reactivity in Chinese patients with type 1 diabetes.
    Xian Y; Xu H; Gao Y; Yan J; Lv J; Ren W; Huang Q; Jiang Z; Xu F; Yao B; Weng J
    Diabetes Metab Res Rev; 2020 Feb; 36(2):e3228. PubMed ID: 31655017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological characteristics of preproinsulin-specific CD8+ T cells in subjects with juvenile-onset and adult-onset type 1 diabetes: A 1-year follow-up study.
    Paul M; Badal D; Jacob N; Dayal D; Kumar R; Bhansali A; Bhadada SK; Sachdeva N
    Pediatr Diabetes; 2018 Feb; 19(1):68-79. PubMed ID: 28488272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel IGRP epitopes targeted in type 1 diabetes patients.
    Jarchum I; Nichol L; Trucco M; Santamaria P; DiLorenzo TP
    Clin Immunol; 2008 Jun; 127(3):359-65. PubMed ID: 18358785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
    Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
    BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope.
    Yang J; Danke N; Roti M; Huston L; Greenbaum C; Pihoker C; James E; Kwok WW
    J Autoimmun; 2008 Aug; 31(1):30-41. PubMed ID: 18385016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.